{
    "2019-07-31": [
        [
            {
                "time": "2019-07-31",
                "original_text": "有34家公司获重要股东增减持，延安必康已被连续减持89次，减持股份。",
                "features": {
                    "keywords": [
                        "增减持",
                        "延安必康",
                        "连续减持"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "金融"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2019-07-31",
                "original_text": "暴风冯鑫行贿非国家工作人员被拘。",
                "features": {
                    "keywords": [
                        "暴风",
                        "冯鑫",
                        "行贿",
                        "被拘"
                    ],
                    "sentiment_score": -0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2019-07-31",
                "original_text": "第二轮科创板打新本周开启，平均市盈率高于第一批。",
                "features": {
                    "keywords": [
                        "科创板",
                        "打新",
                        "市盈率"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "科技",
                        "金融"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-07-31",
                "original_text": "K药上半年收入逼近50亿美元，福建药招新动向。",
                "features": {
                    "keywords": [
                        "K药",
                        "收入",
                        "福建药招"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-07-31",
                "original_text": "北上资金净卖出贵州茅台2.34亿、五粮液1.8亿元。",
                "features": {
                    "keywords": [
                        "北上资金",
                        "贵州茅台",
                        "五粮液",
                        "净卖出"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "消费"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2019-07-31",
                "original_text": "恒瑞医药：SHR-1316注射液获得临床试验通知书。",
                "features": {
                    "keywords": [
                        "恒瑞医药",
                        "临床试验",
                        "通知书"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-07-31",
                "original_text": "19家药企入选国家技术创新示范企业。",
                "features": {
                    "keywords": [
                        "药企",
                        "技术创新",
                        "示范企业"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-07-31",
                "original_text": "中药保护申请16项证明事项取消，荐5股。",
                "features": {
                    "keywords": [
                        "中药",
                        "保护申请",
                        "取消",
                        "荐股"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-07-31",
                "original_text": "医药产业迎来发展大变革，药企纷纷走上创新之路。",
                "features": {
                    "keywords": [
                        "医药产业",
                        "发展变革",
                        "创新"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-07-31",
                "original_text": "辉瑞剥离伟哥等明星药物，专注创新药应对变化市场。",
                "features": {
                    "keywords": [
                        "辉瑞",
                        "剥离",
                        "伟哥",
                        "创新药"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}